Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2024PLoS ONEOpen Access

New genomic techniques, old divides: Stakeholder attitudes towards new biotechnology regulation in the EU and UK

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJonathan MenarySFSebastian Fuller

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Menary et al. (2024) studied this question.

synapsesocial.com/papers/68e7569cb6db6435876cea44https://doi.org/10.1371/journal.pone.0287276
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Will European Consumers and Stakeholders accept New Genomic Techniques ( <scp>NGTs</scp> ) in Food Production?2026
  2. 2Legal regulation of the use of genomic technologies in agriculture: the evolution of approaches in foreign law2025 · 1 citations
  3. 3Enabling regulatory policy globally will promote realization of the potential of animal biotechnology2024 · 13 citations
  4. 4Where does the EU-path on new genomic techniques lead us?2024 · 24 citations
  5. 5The European Union’s deregulation of plants obtained from new genomic techniques: a critique and an alternative option2024 · 5 citations